Literature DB >> 7869194

Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression.

A Viganó1, N Principi, M L Villa, C Riva, L Crupi, D Trabattoni, G M Shearer, M Clerici.   

Abstract

Cytokine production of unstimulated and mitogen-stimulated peripheral blood mononuclear cells of 31 children vertically infected with human immunodeficiency virus type 1 (HIV) and with different patterns of disease progression was evaluated to establish possible correlations between the immunologic and the clinical findings. Production of interferon gamma and interleukin-2 (type 1 cytokines), and of interleukin-4 and interleukin-10 (type 2 cytokines), was analyzed in seven symptom-free patients (Centers for Disease Control and Prevention class P-1B), 10 patients with mild symptoms (class P-2A), and 14 patients with severe symptoms (class P-2B-F). Cytokine production was compared with that of 10 age- and sex-matched control subjects who were seronegative for HIV. The HIV-infected patients produced significantly fewer type 1 cytokines and significantly more type 2 cytokines than the uninfected control subjects. No differences in the production of interferon gamma and interleukin-2 were detected among the different clinical categories of HIV-infected patients. In contrast, interleukin-4 production was augmented in the patients with class P-2A (p < 0.05) and class P-2B-F HIV infection (p < 0.03), in comparison with the children with class P-1B infection. The increase in interleukin-4 production was paralleled by an increase in the number of children with hyperimmunoglobulinemia E in each of the clinical groups (0% in class P-1B; 40% in class P-2A; and 71% in class P-2 B-F infection). Similarly, interleukin-10 production was increased both in patients with class P-2A and in those with class P-2B-F infection, in comparison with the children with class P-1B disease (p < 0.006 and < 0.04, respectively). These data indicate (1) that vertically acquired HIV infection results in decreased production of type 1 cytokines and in increased production of type 2 cytokines, and (2) that an increased production of type 2 cytokines correlates with hyperimmunoglobulinemia E and is present in, and may be characteristic of, the symptomatic phases of childhood HIV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7869194     DOI: 10.1016/s0022-3476(95)70450-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Recombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211).

Authors:  W T Shearer; M W Kline; S L Abramson; T Fenton; S E Starr; S D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Cytokine production in cell culture by peripheral blood mononuclear cells from immunocompetent hosts.

Authors:  R K Katial; D Sachanandani; C Pinney; M M Lieberman
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

3.  Paediatric HIV infection.

Authors:  M Sharland; D Gibb; G Tudor-Williams; S Walters; V Novelli
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

4.  Diagnosis of human immunodeficiency virus infection using an immunoglobulin E-based assay.

Authors:  M Fletcher; M J Miguez-Burbano; G Shor-Posner; V Lopez; H Lai; M K Baum
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

5.  Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus.

Authors:  B N Lee; J G Lu; M W Kline; M Paul; M Doyle; C Kozinetz; W T Shearer; J M Reuben
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

Review 6.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 7.  T helper cell activation and human retroviral pathogenesis.

Authors:  K F Copeland; J L Heeney
Journal:  Microbiol Rev       Date:  1996-12

8.  Enhanced interferon-gamma by CD8+ CD28- lymphocytes from HIV+ patients.

Authors:  E H Eylar; C Lefranc; I Báez; S L Colón-Martinez; Y Yamamura; N Rodriguez; N Yano; T B Breithaupt
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

9.  Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.

Authors:  M S Orandle; K C Williams; A G MacLean; S V Westmoreland; A A Lackner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

10.  TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths.

Authors:  Steven D Douglas; Stephen Durako; Kathleen E Sullivan; Margaret Camarca; Anna-Barbara Moscicki; Craig M Wilson
Journal:  Clin Diagn Lab Immunol       Date:  2003-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.